Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to fall 23.82% to -25 cents per share on March 21

Q4'24

Est.

$-0.25

Q3'24

Missed

by $0.08

Q2'24

Missed

by $0.24

Q1'24

Missed

by $0.06

Q4'23

Est.

$-0.24

The last earnings report on November 08 showed earnings per share of -33 cents, missing the estimate of -25 cents. With 86.85K shares outstanding, the current market capitalization sits at 371.85M.

View a ticker or compare two or three

Compare

HUMA